UK Leads European Research Programme with £10M Investment

The UK has made its first substantial commitment to a major emerging pan-European science project with a £10M investment by the Biotechnology and Biological Sciences Research Council (BBSRC). BBSRC has awarded funding to the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), based at Hinxton near Cambridge, to permit a dramatic increase in the institute's data storage and handling capacity. The funding is the first step in developing the existing data resources and IT infrastructure of EMBL-EBI towards its planned role as the central hub of the emerging European Life-Science Infrastructure for Biological Information (ELIXIR), placing the UK at the forefront of this multinational initiative. The estimated total cost of establishing ELIXIR is significantly more than £200M.

Modern bioscience research, including the new generation of high through-put sequencing technologies, generates huge amounts of data. In order to use the data efficiently and to accelerate bioscience advances, such as the development of new drugs and therapies or higher yielding crops, scientists require better ways to deal with this avalanche of information.

ELIXIR is an initiative involving 32 partners from 13 countries aimed at establishing a sustainably funded infrastructure for biological information in Europe. It will support life science research and its applications to medicine, agriculture and food security, the environment, the bio-industries and society.

The UK's involvement in ELIXIR is supported by BBSRC, MRC, NERC and the Wellcome Trust.

EMBL-EBI Director and ELIXIR coordinator, Professor Janet Thornton, said: "The UK's decision to invest in ELIXIR is an important milestone in creating the infrastructure for biological information in Europe. The EBI will form the hub of a network of ELIXIR nodes that will empower European science at the interface of biology, computing and data management - one of the most vibrant areas of contemporary research. In particular it means that we will be able to implement next-generation datahandling and storage solutions, which will be able to cope with the flood of biological data and fuel future developments in basic biology, medicine, agriculture and environmental sciences."

Professor Doug Kell, Chief Executive of BBSRC, said: "Biology is an information science that is rich in data. UK science funders and EMBL-EBI are committed to ensuring that our researchers can use the latest computational technologies to store, access and analyse the huge amounts of data generated in contemporary bioscience, and thereby to turn them into knowledge and information. These data hold the key to tackling some of our most pressing challenges such as feeding an expanding world population, coping with climate change and providing new, high-efficacy therapeutics with minimal side effects. The UK will now be at the hub of an exciting European partnership to accelerate the application of science in these and other areas."

For further information, please visit:
http://www.ebi.ac.uk

About EMBL-EBI
The European Bioinformatics Institute (EBI) is a non-profit academic organisation that forms part of the European Molecular Biology Laboratory (EMBL).

The EBI is a centre for research and services in bioinformatics. The Institute manages databases of biological data including nucleic acid, protein sequences and macromolecular structures.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...